191 related articles for article (PubMed ID: 16144296)
1. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.
Baumann L; Vujevich J; Halem M; Martin LK; Kerdel F; Lazarus M; Pacheco H; Black L; Bryde J
Cutis; 2005 Jul; 76(1):69-73. PubMed ID: 16144296
[TBL] [Abstract][Full Text] [Related]
2. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
[TBL] [Abstract][Full Text] [Related]
4. Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging.
Bagatin E; Gonçalves HS; Sato M; Almeida LMC; Miot HA
Eur J Dermatol; 2018 Jun; 28(3):343-350. PubMed ID: 30105991
[TBL] [Abstract][Full Text] [Related]
5. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
[TBL] [Abstract][Full Text] [Related]
6. Alitretinoin: a comprehensive review.
Cheng C; Michaels J; Scheinfeld N
Expert Opin Investig Drugs; 2008 Mar; 17(3):437-43. PubMed ID: 18321241
[TBL] [Abstract][Full Text] [Related]
7. Sustained improvement with prolonged topical tretinoin (retinoic acid) for photoaged skin.
Ellis CN; Weiss JS; Hamilton TA; Headington JT; Zelickson AS; Voorhees JJ
J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):629-37. PubMed ID: 2229490
[TBL] [Abstract][Full Text] [Related]
8. Cosmeceuticals: focus on topical retinoids in photoaging.
Serri R; Iorizzo M
Clin Dermatol; 2008; 26(6):633-5. PubMed ID: 18940544
[TBL] [Abstract][Full Text] [Related]
9. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
Sakuta T; Kanayama T
Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of topical retinoids.
Kang S
Cutis; 2005 Feb; 75(2 Suppl):10-3; discussion 13. PubMed ID: 15773538
[TBL] [Abstract][Full Text] [Related]
11. Current status of topical tretinoin in the treatment of photoaged skin.
Kligman AM
Drugs Aging; 1992; 2(1):7-13. PubMed ID: 1554975
[TBL] [Abstract][Full Text] [Related]
12. The use of retinoids in the treatment of photoaging.
Singh M; Griffiths CE
Dermatol Ther; 2006; 19(5):297-305. PubMed ID: 17014485
[TBL] [Abstract][Full Text] [Related]
13. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams.
Griffiths CE; Kang S; Ellis CN; Kim KJ; Finkel LJ; Ortiz-Ferrer LC; White GM; Hamilton TA; Voorhees JJ
Arch Dermatol; 1995 Sep; 131(9):1037-44. PubMed ID: 7544967
[TBL] [Abstract][Full Text] [Related]
14. The role of topical retinoids in the treatment of photoaging.
Stratigos AJ; Katsambas AD
Drugs; 2005; 65(8):1061-72. PubMed ID: 15907143
[TBL] [Abstract][Full Text] [Related]
15. Photoaging and tretinoin.
Kang S
Dermatol Clin; 1998 Apr; 16(2):357-64. PubMed ID: 9589209
[TBL] [Abstract][Full Text] [Related]
16. Topical retinoic acid for photoaging: clinical response and underlying mechanisms.
Griffiths CE; Voorhees JJ
Skin Pharmacol; 1993; 6 Suppl 1():70-7. PubMed ID: 8142114
[TBL] [Abstract][Full Text] [Related]
17. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
[TBL] [Abstract][Full Text] [Related]
18. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel.
Sefton J; Kligman AM; Kopper SC; Lue JC; Gibson JR
J Am Acad Dermatol; 2000 Oct; 43(4):656-63. PubMed ID: 11004622
[TBL] [Abstract][Full Text] [Related]
19. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.
Sachs DL; Kang S; Hammerberg C; Helfrich Y; Karimipour D; Orringer J; Johnson T; Hamilton TA; Fisher G; Voorhees JJ
Arch Dermatol; 2009 Jun; 145(6):659-66. PubMed ID: 19528421
[TBL] [Abstract][Full Text] [Related]
20. Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study.
Hofmann WK; Kell WJ; Fenaux P; Castaigne S; Ganser A; Chomienne C; Burnett R; Kowal C; Hoelzer D; Burnett AK
Leukemia; 2000 Sep; 14(9):1583-8. PubMed ID: 10995004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
